A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma

PURPOSE: Sorafenib is an effective therapy for advanced hepatocellular carcinoma (HCC). Hand–foot syndrome (HFS) is a serious adverse effect associated with sorafenib therapy. This study aimed to develop an updated clinical prediction tool that allows personalized prediction of HFS following sorafen...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuhelwa, Ahmad Y., Badaoui, Sarah, Yuen, Hoi-Yee, McKinnon, Ross A., Ruanglertboon, Warit, Shankaran, Kiran, Tuteja, Anniepreet, Sorich, Michael J., Hopkins, Ashley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956540/
https://www.ncbi.nlm.nih.gov/pubmed/35226112
http://dx.doi.org/10.1007/s00280-022-04411-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956540/
https://www.ncbi.nlm.nih.gov/pubmed/35226112
http://dx.doi.org/10.1007/s00280-022-04411-9

Ejemplares similares